Organ Transport Devices Market

Organ Transport Devices Market Outlook (2022 to 2032)

[250 Pages Report] The global organ transport devices market is set to reach a valuation of USD 115.1 Million in 2022 and expand at a CAGR of 8.7% in the forecast period (2022 to 2032). The global market is projected to reach USD 265.1 Million by the end of 2032.

Attributes	Key Statistics
Global Organ Transport Devices Market Estimated Value (2022E)	USD 115.1 Million
Projected Market Valuation (2032F)	USD 265.1 Million
Value-based CAGR (2022 to 2032)	8.7%
Collective Value Share: Top 5 Countries (2022E)	55.2%

The organ transport devices industry held approximately 51.4% of the global organ preservation market in 2021 which was worth USD 206.1 Million.

Rising incidence of organ failure is expected to lead to increasing number of organ transplant surgeries performed around the world. Over the projected period, the market for organ transport devices is expected to grow at a fast pace due to increasing prevalence of chronic diseases.

Cardiovascular disorders, for instance, have become one of the leading causes of death and morbidity in the past three decades. According to the American Heart Association (AHA), in 2021, cardiovascular disease (CVD) affected about 92.1 million individuals in the U.S. and it is the leading cause of death in the country, as compared to other chronic conditions.

High prevalence of organ malfunction, especially of the kidney, liver, and heart, is becoming common among the geriatric population. According to the United States Government Information on Organ Donation and Transplantation, 63 per cent of those who received organ transplants in 2019 were 50 years or older, and 21% of all organ transplant patients were 65 years or older. These numbers are projected to grow rapidly in the assessment period, thereby driving demand for organ transport devices.

2017-2021 Organ Transport Devices Demand Outlook Compared to 2022 to 2032 Forecast

Sales of organ transport devices have expanded in recent years owing to increased adoption of advanced devices and solutions. Various advantages of organ transport devices such as ease of transport and fast delivery of required organs at the right place, over other available devices in the market, is also set to push growth.

Over the forecast period, the market for organ transport devices is expected to be influenced by increased government initiatives to promote organ donation.

As per the National Kidney Foundation, at present, there are about 121,678 people waiting for lifesaving organ transplants in the U.S. Out of these, nearly 100,791 individuals are waiting for kidney transplants. Owing to the above-mentioned factors, sales of organ transport devices are projected to surge in the evaluation period.

In addition, several companies in the organ transport devices market are implementing a variety of organic strategies that would result in dynamic market improvements. They are mainly focusing on new product launches, product approvals, and development to increase sales.

For instance, TransMedics Group, Inc. received the U.S. FDA premarket approval for its OCS Liver System to preserve organs following DCD and DCBD in September 2021. The OCS Liver System would help preserve and observe metabolic and hemodynamics functions that would further enable ex-vivo assessment from DBD and DCD donor livers of liver allografts.

Spurred by the aforementioned factors, the global organ transport devices market is likely to grow at a CAGR of 8.7% from 2022 to 2032.

Download Report Brochure

How is Diabetes Affecting the Global Organ Transport Devices Market?

Governments of various countries worldwide are working to improve their healthcare infrastructures to deliver better services. Infrastructure improvement programs are set to help several hospitals to treat more brain-dead patients who may be acceptable donors.

Increasing establishment of testing laboratories and transplant centers across the globe is estimated to reduce the time spent on donor-recipient compatibility, subject profiling, genotyping, and other relevant diagnostic procedures during organ transplantations.

In addition, the industry will be boosted by increased risk of organ failure among patients suffering from chronic diseases. As per the WHO, about 34.2 million people in the U.S. are currently living with diabetes. Rising prevalence of diabetes is anticipated to result in kidney failures, thereby providing new opportunities to key players from 2022 to 2032.

Which Factors May Hinder the Demand for Organ Transport Devices?

Currently, there is a considerable disparity between the number of organs donated and those required. In the U.S., there were over 100,000 people on the organ transplant waiting list as of January 2022. By the end of 2021, only 41,354 transplants had been completed. The low number of organs donated each year is primarily owing to lack of organ donation awareness, ineffective legislative measures, and increased risk of organ trafficking.

Governments of various countries are also implementing reformed regulations such as opt-out laws that imply every citizen is an organ donor unless exempted and campaigns to encourage people to donate organs. However, these regulations are hampering growth in the organ transport devices market as there is a discrepancy between expected improved deceased organ donations and actual rates of deceased organ donations.

Country-wise Insights

What Makes the U.S. the Largest Market for Organ Transport Devices?

“Rising Prevalence of Organ Failure to Push the U.S. Market”

The U.S. held about 92.4% of the North America organ transport devices market share in 2021 and is expected to lead throughout the forecast period. The U.S. is considered to be the most lucrative market for organ transport devices owing to high prevalence rate of chronic disorders in the country.

Increasing cases of kidney failure in the U.S. on the back of diabetes and high blood pressure is projected to aid growth. It is further set to push the need for organ transplantation procedures and thus propel the U.S. market.

Why is the U.K. Showcasing Lucrative Growth in the Organ Transport Devices Market?

“Surging Number of Transplant Surgeries to Drive the U.K. Market”

The U.K. generated a share of approximately 20.2% in 2021 in the Europe organ transport devices market. Growth is attributed to increasing procedural rate of organ transplantation in the country.

According to the NHS 2019 Report, over 8,740 liver transplants were reported in the U.K. during the past ten years. On account of this, use of organ transport devices is projected to grow in the forthcoming years, thereby driving the U.K. market.

What Makes China an Emerging Market for Organ Transport Devices?

“Chronic Diseases among Geriatric Population to Push Growth”

China held around 57.4% share in the East Asia organ transport devices market in 2021 and is projected to grow at a rapid pace during the forecast period. Growth is attributed to increasing technological advancements in the field of organ transport in the country. Also, rising geriatric population is expected to augment growth in China.

As per the WHO, in 2019, there were 176 million older individuals belonging to the age group of 65 years or older and nearly 254 million people who were 60 years of age or older. Hence, the market for organ transport devices is expected to grow rapidly in China because of high risk of organ failure among the aging population.

Category-wise Insights

Which is the Highly Preferred Product in the Global Organ Transport Devices Market?

“Use of Hypothermic Perfusion Devices to Grow for Kidney Preservation Process”

Based on product, the cold or hypothermic perfusion devices segment is projected to showcase lucrative growth in the evaluation period. The segment held a share of 63.7% in 2021 in the global organ transport devices market.

Hypothermia is widely used and regarded as the gold standard treatment for organ preservation. Kidneys, liver, lungs, pancreas, and heart are all preserved with this method across the globe, which would push its demand in the next decade.

Which Organ is Expected to Dominate the Organ Transport Devices Market?

“Number of Kidney Transplant Surgeries to Grow in 2022-2032”

In terms of organ, the kidney segment held a revenue share of 62.0% in 2021 and is expected to grow at a considerable pace over the forecast period with a CAGR of 8.5%. Increasing number of kidney transplantation procedures across the globe with rising prevalence of chronic kidney disease and subsequent kidney failure is projected to boost the segment.

According to the CDC, chronic kidney disease affects nearly 15.0 per cent of adults in the U.S. each year. Thus, increasing number of kidney transplantation procedures is set to spur the use of novel organ transport devices.

Which is the Leading End User of Organ Transport Devices?

“Transplant Centers to Adopt New Organ Transport Devices”

Based on end user, the transplant centers segment held about 67.4% of the organ transport devices market share in 2021. Increasing number of transplant centers around the world is a major factor that is projected to drive the segment. Governments of various countries are likely to invest in the enhancement of healthcare infrastructure, which would also push the segment.

Competitive Landscape

Key players in the organ transport devices market are focusing on expanding their presence globally and are striving to broaden their product offerings to gain a competitive edge.

Meanwhile, some of the other companies are engaging in mergers, acquisitions, agreements, and collaborations to improve their existing product portfolios. They are also aiming to expand their manufacturing capacities to generate more shares.

Some of the recent developments in the global organ transport devices market are:

• In December 2021, XVIVO Perfusion teamed up with Contatti Medical to develop its new company and gain access to a comprehensive network of transplantation hospitals in Latin America's largest country, Brazil.
• In October 2021, Paragonix Technologies announced the launch of LIVERguard Donor Liver Preservation System in the U.S. and the region of Europe.
• In July 2021, Institut Georges Lopez increased its footprint by establishing a new manufacturing facility in Cheyyar, Tamil Nadu, India to produce medical devices and treatment options for organ cleaning and preservation.

Scope of the Report

Attributes	Details
Estimated Market Size (2022)	USD 115.1 Million
Projected Market Valuation (2032)	USD 265.1 Million
Value-based CAGR (2022 to 2032)	8.7%
Forecast Period	2022 to 2032
Historical Data Available for	2017 to 2021
Market Analysis	USD Million for Value
Key Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC countries, Turkey, and North Africa.
Key Market Segments Covered	Products, Organ, End User, and Region
Key Companies Profiled	TransMedics Inc.; Paragonix Technologies; Organ Recovery Systems; XVIVO Perfusion AB; OrganOx Limited; X-Therma Inc.; Bridge to Life; French Institut Georges Lopez (IGL); EBERS Medical Technology SL. (Spain); Vascular Perfusion Solutions (USA); tritec®; B Medical Systems; LMB Technologie GmbH
Report Coverage	Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Organ Transport Devices Market Outlook by Category

By Product:

• Warm or Normothermic Perfusion Devices
• Cold or Hypothermic Perfusion Devices

By Organ:

• Liver
• Heart
• Kidney
• Lung
• Others (Pancreas, Small Intestine)

By End User:

• Hospitals
• Transplant Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa (MEA)

Frequently Asked Questions

How much was the global organ transport devices market worth in 2021?

The global organ transport devices market was worth USD 105.9 Mn in 2021 and is set to expand 2.3x over the next ten years.

What is the sales forecast for organ transport devices through 2032?

The organ transport devices market is expected to reach USD 265.1 Mn by the end of 2032 and register a CAGR of 8.7% in 2022-2032.

What are the key trends shaping the organ transport devices industry?

Favorable government regulations, ongoing developments in the field of organ preservation devices, and growing R&D activities for the development of cost-effective services are some of the key trends shaping the organ transport devices industry.

Which are the top 5 countries driving demand for organ transport devices?

The U.S., China, the U.K., Germany, and Japan are expected to drive demand for organ transport devices.

What is the U.S. organ transport devices market outlook?

The U.S. accounted for nearly 92.4% of the North America organ transport devices market in 2021.

How is the Europe organ transport devices market progressing?

The Europe organ transport devices market is expected to register growth at a CAGR of 8.9% over the next ten years.

Which countries are key producers of organ transport devices?

The U.S., Germany, and China are key producers of organ transport devices.

Who are the key organ transport devices manufacturers?

TransMedics Inc., Paragonix Technologies, Organ Recovery Systems, XVIVO Perfusion AB, OrganOx Limited, X-Therma Inc., Bridge to Life, and French Institut Georges Lopez (IGL) are the key organ transport devices manufacturers.